Skip to main content
TipRanks
Go Ultimate75% OFF

Pharma Mar SA (PHM) Stock Statistics & Valuation Metrics

23 Followers

Total Valuation

Pharma Mar SA has a market cap or net worth of EUR 1.19B. The enterprise value is EUR 1.16B.

Market Cap
EUR 1.19B
Enterprise Value
EUR 1.16B

Share Statistics

Pharma Mar SA has 18,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
18,000,000
Owned by Insiders
―
Owned by Institutions
8.55%

Financial Efficiency

Pharma Mar SA’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 12.83%.

Return on Equity (ROE)
0.30
Return on Assets (ROA)
0.19
Return on Invested Capital (ROIC)
12.83%
Return on Capital Employed (ROCE)
0.13
Revenue Per Employee
438.40K
Profits Per Employee
148.49K
Employee Count
505
Asset Turnover
0.56
Inventory Turnover
0.24

Valuation Ratios

The current PE Ratio of Pharma Mar SA is 16.93. Pharma Mar SA’s PEG ratio is 0.16.

PE Ratio
16.93
PS Ratio
4.91
PB Ratio
4.92
Price to FCF
28.10
Price to Operating Cash Flow
22.08
PEG Ratio
0.16

Income Statement

In the last 12 months, Pharma Mar SA had revenue of 221.39M and earned 74.99M in profits. Earnings per share was 4.30.

Revenue
221.39M
Gross Profit
209.13M
Operating Income
40.28M
Pretax Income
59.65M
Net Income
74.99M
EBITDA
48.30M
Earnings Per Share (EPS)
4.30

Cash Flow

In the last 12 months, operating cash flow was 52.80M and capital expenditures -11.31M, giving a free cash flow of 41.49M billion.

Operating Cash Flow
52.80M
Free Cash Flow
41.49M
Free Cash Flow per Share
2.39

Dividends & Yields

Pharma Mar SA pays an annual dividend of EUR 1.00, resulting in a dividend yield of 1.49%

Dividend Per Share
EUR 1.00
Dividend Yield
1.49%
Payout Ratio
21.65%
Free Cash Flow Yield
3.56%
Earnings Yield
5.86%

Stock Price Statistics

Beta
0.50
52-Week Price Change
-10.93%
50-Day Moving Average
70.98
200-Day Moving Average
81.01
Relative Strength Index (RSI)
44.97
Average Volume (3m)
33.16K

Important Dates

Pharma Mar SA upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Mar 01, 2027
Ex-Dividend Date
Jul 08, 2026

Financial Position

Pharma Mar SA as a current ratio of 3.02, with Debt / Equity ratio of 19.62%

Current Ratio
3.02
Quick Ratio
2.48
Debt to Market Cap
0.04
Net Debt to EBITDA
0.65
Interest Coverage Ratio
16.38

Taxes

In the past 12 months, Pharma Mar SA has paid -15.34M in taxes.

Income Tax
-15.34M
Effective Tax Rate
-0.26

Enterprise Valuation

Pharma Mar SA EV to EBITDA ratio is 21.74, with an EV/FCF ratio of 28.71.

EV to Sales
5.02
EV to EBITDA
21.74
EV to Free Cash Flow
28.71
EV to Operating Cash Flow
22.56

Balance Sheet

Pharma Mar SA has EUR 176.29M in cash and marketable securities with EUR 70.07M in debt, giving a net cash position of EUR 106.23M billion.

Cash & Marketable Securities
EUR 176.29M
Total Debt
EUR 70.07M
Net Cash
EUR 106.23M
Net Cash Per Share
EUR 5.90
Tangible Book Value Per Share
EUR 13.44

Margins

Gross margin is 91.59%, with operating margin of 19.57%, and net profit margin of 28.80%.

Gross Margin
91.59%
Operating Margin
19.57%
Pretax Margin
22.34%
Net Profit Margin
28.80%
EBITDA Margin
23.09%
EBIT Margin
19.57%

Analyst Forecast

The average price target for Pharma Mar SA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
32.42%
EPS Growth Forecast
103.06%

Scores

Smart Score
4
AI Score
65